Drug Discovery Award

The Drug Discovery Award is a program that supports academic investigators working to discover and advance new therapeutic agents into preclinical development for cancer. The award provides resources to support post-target validation through early lead development and access to expertise from experienced biopharma R&D scientists who advise on critical-path activities toward developing a new therapeutic agent. It is administered by The Mark Foundation for Cancer Research.

Resources to support post-target validation and early lead development; advisory expertise from seasoned biopharma R&D scientists.

Academic investigators working to discover and progress new therapeutic agents into preclinical development.